Bibliographic Details
| Title: |
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine. |
| Authors: |
Beatriz Moreno, Iciar Lopez, Begoña Fernández-Díez, Miroslav Gottlieb, Carlos Matute, María Victoria Sánchez-Gómez, María Domercq, Albert Giralt, Jordi Alberch, Kevin W Collon, Helen Zhang, Jack M Parent, Meritxell Teixido, Ernest Giralt, Valentín Ceña, Inmaculada Posadas, Eva Martínez-Pinilla, Pablo Villoslada, Rafael Franco |
| Source: |
PLoS ONE, Vol 9, Iss 3, p e90671 (2014) |
| Publisher Information: |
Public Library of Science (PLoS), 2014. |
| Publication Year: |
2014 |
| Collection: |
LCC:Medicine
LCC:Science |
| Subject Terms: |
Medicine, Science |
| More Details: |
Background5'-deoxy-5'-methylthioadenosine (MTA) is an endogenous compound produced through the metabolism of polyamines. The therapeutic potential of MTA has been assayed mainly in liver diseases and, more recently, in animal models of multiple sclerosis. The aim of this study was to determine the neuroprotective effect of this molecule in vitro and to assess whether MTA can cross the blood brain barrier (BBB) in order to also analyze its potential neuroprotective efficacy in vivo.MethodsNeuroprotection was assessed in vitro using models of excitotoxicity in primary neurons, mixed astrocyte-neuron and primary oligodendrocyte cultures. The capacity of MTA to cross the BBB was measured in an artificial membrane assay and using an in vitro cell model. Finally, in vivo tests were performed in models of hypoxic brain damage, Parkinson's disease and epilepsy.ResultsMTA displays a wide array of neuroprotective activities against different insults in vitro. While the data from the two complementary approaches adopted indicate that MTA is likely to cross the BBB, the in vivo data showed that MTA may provide therapeutic benefits in specific circumstances. Whereas MTA reduced the neuronal cell death in pilocarpine-induced status epilepticus and the size of the lesion in global but not focal ischemic brain damage, it was ineffective in preserving dopaminergic neurons of the substantia nigra in the 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP)-mice model. However, in this model of Parkinson's disease the combined administration of MTA and an A2A adenosine receptor antagonist did produce significant neuroprotection in this brain region.ConclusionMTA may potentially offer therapeutic neuroprotection. |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
1932-6203 |
| Relation: |
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0090671&type=printable; https://doaj.org/toc/1932-6203 |
| DOI: |
10.1371/journal.pone.0090671&type=printable |
| DOI: |
10.1371/journal.pone.0090671 |
| Access URL: |
https://doaj.org/article/375da3cf40494ec0a03f83ee7067971a |
| Accession Number: |
edsdoj.375da3cf40494ec0a03f83ee7067971a |
| Database: |
Directory of Open Access Journals |
